Literature DB >> 32955729

The science and rationale of arriving at the correct drug and dosimetry of griseofulvin, fluconazole, terbinafine and itraconazole in superficial dermatophyte infections: an important step before a pragmatic trial.

K Sardana1, S R Mathachan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32955729     DOI： 10.1111/bjd.19562

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

1.  Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial.

Authors:  Ananta Khurana; Aastha Agarwal; Diksha Agrawal; Sanjeet Panesar; Manik Ghadlinge; Kabir Sardana; Khushboo Sethia; Shalini Malhotra; Ankit Chauhan; Nirmala Mehta
Journal:  JAMA Dermatol       Date:  2022-09-14       Impact factor: 11.816

2.  Oral Isotretinoin Combined with Oral Terbinafine Versus Oral Terbinafine Alone to Treat Recurrent Dermatophytosis: An Open-Label Randomised Clinical Trial.

Authors:  Kaushal K Verma; Gridharan Senthilnathan; Saurabh Bhatia; Immaculata Xess; Vishal Gupta; Sada Nand Dwivedi; Kanika Sahni
Journal:  Indian Dermatol Online J       Date:  2021-11-22

3.  Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates from Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation.

Authors:  Kabir Sardana; Aastha Gupta; Suresh Sadhasivam; R K Gautam; Ananta Khurana; Swamini Saini; Swati Gupta; Shamik Ghosh
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.